Machina Capital S.A.S. Edwards Lifesciences Corp Transaction History

Machina Capital S.A.S.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $214,010 - $269,671	-3,468 Reduced 48.72%	3,650 $278,000
Q3 2023 Nov 02, 2023	BUY	$69.28 - $93.38 $493,135 - $664,678	7,118 New	7,118 $493,000
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $280,305 - $365,107	3,403 New	3,403 $271,000
Q4 2021 Jan 21, 2022	SELL	$106.37 - $130.68 $351,021 - $431,244	-3,300 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $339,603 - $405,075	3,300 New	3,300 $374,000
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $51,571 - $79,704	-984 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $75,285 - $86,194	-1,050 Reduced 51.62%	984 $230,000
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $37,483 - $45,936	609 Added 42.74%	2,034 $447,000
Q2 2019 Jul 19, 2019	BUY	$55.74 - $64.41 $79,429 - $91,784	1,425 New	1,425 $263,000
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $4,645 - $6,212	-97 Closed	0 $0
Q4 2018 Mar 25, 2019	BUY	$46.41 - $56.94 $4,501 - $5,523	97 New	97 $15,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

Stay updated on Machina Capital S.A.S. with notifications on news.